Racquel Racadio is the Director of Global Representation in Clinical Research at Amgen, where she leads a team that is dedicated to improving the diversity and proportional representation of patients from historically excluded groups in Amgen’s clinical research programs.
Racquel has been at Amgen for over 4 years, and, in addition to her role in clinical research, she serves as Diversity Council Champion for the Global Medical Organization and as a member of the Senior Leadership Team for the Amgen Black Employee Network. Racquel is also the global Co-Lead of the TransCelerate BioPharma Diversity of Participants in Clinical Trials Initiative Workstream and serves as an SME representing Amgen on the majority of the cross-industry collaboration projects focused on diversity in clinical trials.
Racquel has nearly 15 years of experience in clinical research and the life sciences, at the start-up, CRO, and sponsor level, including clinical trial oversight, study feasibility, and clinical site selection across multiple therapeutic areas, direct clinical care, and independent consulting for cross-industry consortia. Her background also includes public health research, which has consistently focused on racial, ethnic, and gender disparities in healthcare access and health outcomes, including barriers to prenatal care for women of color, barriers to reproductive care for rural women, and racial disparities in infant mortality.
Racquel is a graduate of the University of Wisconsin-Madison and Milwaukee, an MPH graduate of the Medical College of Wisconsin, and is a DrPH candidate at the University of North Carolina at Chapel Hill Gillings School of Global Public Health, where her dissertation research is studying how technology may reduce barriers to oncology clinical trial participation for participants from racial and ethnic minority communities.
Outside of her day job, Racquel is a mentor for BIPOC women and girls interested in STEM fields to empower them to persist and succeed in their educational and career pursuits.